Trump signs order to extend China tariff truce by 90 days
The White House's halt on steeper tariffs will be in place until 10 November.
"I have just signed an Executive Order that will extend the Tariff Suspension on China for another 90 days," Mr Trump wrote on his Truth Social platform.
While the United States and China slapped escalating tariffs on each other's products this year, bringing them to prohibitive triple-digit levels and snarling trade, both countries in May agreed to temporarily lower them.
Their 90-day halt of steeper levies had been due to expire today.
Around the same time that Mr Trump confirmed the new extension, Chinese state media Xinhua news agency published a joint statement from US-China talks in Stockholm saying it would also extend its side of the truce.
China will continue suspending its earlier tariff hike for 90 days starting 12 August while retaining a 10% duty, the report said.
It would also "take or maintain necessary measures to suspend or remove non-tariff countermeasures against the United States, as agreed in the Geneva joint declaration," Xinhua reported.
In the executive order posted to its website, the White House reiterated its position that there are "large and persistent annual US goods trade deficits" and they "constitute an unusual and extraordinary threat to the national security and economy of the United States."
The order acknowledged Washington's ongoing discussions with China "to address the lack of trade reciprocity in our economic relationship" and noted that China has continued to "take significant steps toward remedying" the US complaints.
The 90-day extension means the truce is now set to expire just after midnight on 10 November.
Concessions
"Beijing will be happy to keep the US-China negotiation going, but it is unlikely to make concessions," warned William Yang, an analyst at the International Crisis Group.
He believes China sees its leverage over rare earth exports as a strong one, and that the Chinese government will likely use it to pressure the US.
US-China Business Council president Sean Stein said the current extension is "critical to give the two governments time to negotiate an agreement" providing much-needed certainty for companies to make plans.
Even as both countries reached a pact to cool tensions after high level talks in Geneva in May, the de-escalation has been shaky.
Key economic officials convened in London in June as disagreements emerged and US officials accused their counterparts of violating the pact. Politicians met again in Stockholm last month.
Mr Trump said in a social media post that he hoped China would "quickly quadruple its soybean orders," adding this would be a way to balance trade with the United States.
As part of their May truce, fresh US tariffs targeting China were reduced to 30% and the corresponding level from China was cut to 10%.
Separately, since returning to the presidency in January, Mr Trump has slapped a 10% "reciprocal" tariff on almost all trading partners, aimed at addressing trade practices the US deemed unfair.
This surged to varying steeper levels last Thursday for dozens of economies.
Major partners like the European Union, Japan and South Korea now see a 15% US duty on many products, while the level went as high as 41% for Syria.
The "reciprocal" tariffs exclude sectors that have been targeted individually, such as steel and aluminum, and those that are being investigated like pharmaceuticals and semiconductors.
They are also expected to exclude gold, although a clarification by US customs authorities made public last week caused concern that certain gold bars might still be targeted.
Mr Trump said that gold imports will not face additional tariffs, without providing further details.
The president has taken separate aim at individual countries such as Brazil over the trial of former president Jair Bolsonaro, who is accused of planning a coup, and India over its purchase of Russian oil.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
2 minutes ago
- Irish Times
From pharma to food, the known unknowns of Trump's EU tariffs deal
The US/ EU tariff deal was meant to bring certainty for exporters. But almost three weeks later there is a lot that we don't know – and more that remains uncertain. A joint statement signed off by both sides had been expected shortly after the big summit in Scotland at the end of July , clarifying key parts of the deal and how it would be implemented. But this week, a European Commission spokesperson said, in best bureacrateese, that while further contacts with the US were expected on this, 'I don't believe at this stage we can put a timeline on these engagements.' 1. What is covered by the new tariffs? The deal had been hailed as bringing 'certainty' to Irish exporters. And it has done so, but only up to a point. A blanket 15 per cent tariff now applies on most categories or exports from Ireland to the US. READ MORE As ever with trade, there are tweaks. Some goods which had been subject to previous higher tariff charges (under the most favoured nation or MFN system) will still pay these. For Ireland, the main product affected here is butter – with Kerrygold now the second biggest seller on the US market. Before Trump came to office it had been levied at a rate based on weight – rather than the more usual percentage calculation. However, this worked out at somewhere over 16 per cent in practice. So this slightly higher rate will remain. Other sectors face tariffs for the first time, or higher charges. For example, the large medical products sector had previously been largely exempted, but is now being levied at 15 per cent. So are parts of the food sector and spirits. 2. What is not covered? US customs has published a list of goods that are excluded from the 15 per cent tariff and Carol Lynch, customs partner at BDO, says this is a good place for SMEs unsure if they are covered to check. A key point for Ireland is that pharma products, by far the State's biggest in value terms, are not currently subject to the 15 per cent tariff. This may change, as the Trump administration is undertaking a study of pharma supply into the US market and the national security issues that apply – the so-called section 232 investigation which refers back to a 1960s act of congress. This is the backdrop to Trump's talk of 150 per cent or 250 per cent tariffs on pharma in 18 months or two years' time, applying to companies that do not play ball and return production to the US market. The EU believes the US has signed up to a 15 per cent cap on pharma – and semiconductor – tariffs under the deal, but Trump's subsequent statements suggest otherwise. This is why the absence of a joint agreed statement between the EU and US is important. 3. What might change? Another frustration for the EU is that the outline agreement suggested that more areas would be excluded from the 15 per cent tariff net but, beyond aircraft and aircraft parts, none of these has yet been spelt out. These 'carveouts' were due to cover some areas of food of potential interest to Ireland, some generic drugs and chemicals and perhaps medical devices, a sector which typically has lower margins and fixed price contracts with US buyers. The EU had also been pushing for a 'zero for zero' tariff deal on wines and spirits, though the indications were the US was unlikely to concede this. So bar the list published by US Customs, we are no wiser on what other sectors may, in time, get a pass. 4. What can companies do? The practical steps, according to Lynch of BDO, are, first, to check whether goods were in transit before August 7th, in which case the old 10 per cent rate would apply rather than the new 15 per cent. Companies need to know the tariff codes being used by those importing their products and whether any of the exclusions they know about so far apply. And, she says, they need to examine whether they have any flexibility under the rules in terms of the value of goods declared for customs purposes. This is a complex area with detailed pricing rules applying but, particularly in high value sectors like pharma, companies may have options to readjust supply changes or pricing policies to cut their tariff bills. 5. Where next on pharma? The Trump administration has been promising the results of its section 232 investigation shortly, expected by way of a big report. Alongside this, Trump's team have been negotiating on prices with the big US pharma companies, demanding that they charge the same prices in the US as other countries. A 2022 study showed that US prices were, on average, three times higher than the OECD average. This – in Trump's view- means prices should fall in the US and rise in other countries, thus giving the US consumer a better deal while giving companies ongoing revenue to fund research. It is unclear what the outcome of this will be but the two areas are linked. Imposing tariffs on imports risks increasing prices on the US market, the opposite of the goal of the price negotiations. The US president is threatening tariffs which would gradually increase over time as a way of getting big pharma to relocate more production to the US of key drugs and ingredients. So will we see 15 per cent pharma tariffs when the result of the Section 232 probes are out? Or will the US president hold off for now while holding out the threat of tariffs if big pharma does not fall into line on prices and investment? 6. Ireland's pharma exposure: In a post on the pharma issue on LinkedIn, Ben McConkey, an Irish MSc student at the London School of Economics, underlines the extent of Ireland's 'pharma' exposure by pointing out that the US imported over $50 billion worth of Irish pharmaceutical products in 2004, making it the single largest category of goods imported from any EU country by a margin of $15 billion and representing 8.3 per cent of all US imports from the EU. While the noise around the trade talks was about German cars, Irish pharma exports have a higher value, though this is of course hugely inflated by the pricing practices of the firms involved, which have a financial incentive to declare as much profit as possible in low tax Ireland. McConkey also makes the interesting point that the bulk of Irish pharma and organic chemicals go to republican states such as Indiana – home of Eli Lilly – as well as Puerto Rico, North Carolina and Illinois. Many are not finished drugs but are high value ingredients in drugs then sold across the US. As tariffs will have an economic impact on these companies – and on US consumers – it remains to be seen what the president decides. But the stakes for Ireland in the Section 232 process are huge as it could influence both future manufacturing investment and the transfer pricing structures the companies employ which led to huge profits being declared in Ireland and a lot of corporate tax being paid here. 7. The uncertainty may just roll on: The EU's belief was that a joint statement would be agreed with the US on the basis of the political agreement between Trump and European Commission president Ursula von der Leyen in Scotland. This would then be followed by further detailed negotiations. It is unclear if the absence of even a basic, joint written understanding is just a result of August holidays or whether it is a sign of the way the US president tends to operate – in headlines and in a way which leaves him with maximum flexibility to change tack. The president and his team have been continuing to push the boat out in terms of tariffs and pressure on US businesses to bend to their will. There is a fair chance that the uncertainty will roll on – and on. And this in itself will have a cost on businesses, even if the 15 per cent deal will have left many feeling they have some more solid ground on which to plan. And, it must be remembered that the US president's right to impose the 15 per cent tariffs at all is being challenged in the courts – a process likely to go right to the US supreme court for an ultimate decision.
Irish Examiner
an hour ago
- Irish Examiner
World shares mixed ahead of meeting between Trump and Putin
World shares are mixed ahead of a key meeting between Us President Donald Trump and Russian President Vladimir Putin at the end of this week. Bitcoin briefly rose more than 3% to a new record of over 123,000 dollars, according to CoinDesk. It later fell back below 122,000 dollars. A board above the trading floor of the New York Stock Exchange displays the closing number for the Dow Jones industrial average (Richard Drew/AP) The future for the S&P 500 was unchanged, while that for the Dow Jones Industrial Average edged 0.1% higher. Later Thursday, a report will show how bad US inflation was at the wholesale level across the US. Economists expect it to show inflation ticked up to 2.4% in July from 2.3% in June. In early European trading, Germany's DAX rose 0.5% to 24,296.02. In Paris, the CAC 40 added 0.4% to 7,832.60. Europe is bracing for Mr Trump's encounter with Mr Putin, though the US president has said he will prioritise trying to achieve a ceasefire in Ukraine when he meets with Mr Putin on Friday in Anchorage, Alaska. The Trump-Putin meeting could have major implications for energy markets, potentially leading to an easing of sanctions against Moscow, or an escalation if no progress is made on ending the war in Ukraine. Early on Thursday, US benchmark crude rose 28 cents to 62.93 dollars per barrel. Brent crude, the international standard, added 32 cents to 65.95 dollars per barrel. During Asian trading, Tokyo's Nikkei 225 fell nearly 1.5% to 42,649.26 as investors sold to lock in recent gains that have taken the benchmark to all-time records. Currency traders watch monitors near a screen showing the Korea Composite Stock Price Index (Kospi) in Seoul, South Korea (Ahn Young-joon/AP) The Japanese yen rose against the dollar after US treasury secretary Scott Bessent said in an interview with Bloomberg that Japan was 'behind the curve' in monetary tightening. He was referring to the slow pace of increases in Japan's near-zero interest rates. Low interest rates tend to make the yen weaker against the dollar, giving Japanese exporters a cost advantage in overseas sales. The dollar fell to 146.50 Japanese yen Thursday, down from 147.39 yen. The euro slid to 1.1681 dollars from 1.1705 dollars. In Chinese markets, Hong Kong's Hang Seng index shed 0.4% to 25,519.32, while the Shanghai composite index slid 0.5% to 3,666.44. South Korea's Kospi rose less than 0.1% to 3,225.66. In Australia, the S&P ASX 200 index added 0.5% to 8,873.80. Taiwan's Taiex fell 0.5% and India's Sensex edged 0.2% higher. On Wednesday, US stocks ticked higher, extending a global rally fuelled by hopes the Federal Reserve will cut US interest rates. The S&P 500 rose 0.3% and the Dow climbed 1%. The Nasdaq composite added 0.1%. Treasury yields eased in the bond market in anticipation that the Fed will cut its main interest rate for the first time this year at its next meeting in September. Lower rates can boost investment prices and the economy by making it cheaper for US households and businesses to borrow to buy houses, cars or equipment, though they risk worsening inflation. Mr Trump has angrily been calling for cuts to help the economy, often insulting the Fed chairman Jerome Powell while doing so. But the Fed has hesitated, worried that Mr Trump's sweeping higher tariffs could make inflation much worse. Fed officials have said they want to see more fresh data about inflation before moving.
Irish Times
2 hours ago
- Irish Times
Zelenskiy meets Starmer to shore up support ahead of Trump-Putin summit
With just one day to go until a US - Russian summit on ending the war in Ukraine, its president, Volodymyr Zelenskiy , is in London to shore up European support for efforts to prevent any agreement that would carve up his country. Friday's Alaska summit comes at one of the toughest moments for Ukraine in a war – the largest in Europe since the second World War – that has killed tens of thousands and displaced millions since Russia's full-scale invasion in February 2022. On the back foot on the battlefield against Russian forces, Mr Zelenskiy and his allies are keen to avoid any deal between US president Donald Trump and Russian president Vladimir Putin that leaves Ukraine more vulnerable to Russian attacks. Mr Zelenskiy met UK prime minister Keir Starmer to build on momentum from virtual talks held on Wednesday with European leaders and Mr Trump to try to set red lines for the talks between Mr Trump and Mr Putin in Anchorage. Mr Zelenskiy and Sir Keir embraced before heading in to their meeting in Downing Street. READ MORE On Wednesday, Mr Trump threatened 'severe consequences' if Russia's leader does not agree to peace in Ukraine, and while he did not specify what the consequences could be, he has warned of economic sanctions if his meeting on Friday proves fruitless. [ Zelenskiy to visit Downing Street ahead of Trump meeting with Putin Opens in new window ] 'Yesterday was a pivotal moment for reinforcing European and transatlantic unity,' Ukraine's foreign minister Andrii Sybiha said on X. 'We need peace through strength as a foundation for the future of global security and stability.' Yesterday was a pivotal moment for reinforcing European and transatlantic unity. President of Ukraine We need peace… — Andrii Sybiha 🇺🇦 (@andrii_sybiha) Mr Zelenskiy said he warned Mr Trump that Mr Putin was 'bluffing' about his desire to end the war. The Ukrainian leader also said Mr Trump had supported the idea of security guarantees in a postwar settlement. Politico cited people familiar with the situation as saying that Trump had said the US could provide guarantees with some conditions. A source familiar with the matter told Reuters security guarantees were discussed on the call. 'We have no details of his [Mr Trump's] view on this but now he is more open for some kind of US support for the guarantees,' the source said, adding that Mr Trump understood that a US backstop was needed for guarantees to be workable. [ Trump threatens 'very severe consequences' if Putin refuses to end Ukraine war Opens in new window ] Mr Zelenskiy confirmed this week that Russian forces had advanced by about 9-10 km (6 miles) near the town of Dobropillia in the Donetsk region. Ukraine, suffering manpower challenges, was forced to move in reserves to stabilise the situation. Mr Trump's comments and the outcome of the virtual conference on Wednesday could provide encouragement for Kyiv. Mr Trump described the aim of his talks with Mr Putin in Alaska as 'setting the table' for a quick follow-up that would include Mr Zelenskiy. However, Russia is likely to resist Ukraine and other European leaders' demands strongly and previously has said its stance had not changed since it was first detailed by Mr Putin in June 2024. Mr Trump has said a deal could include what he called a land swap. Russia controls around a fifth of Ukraine and a land swap within Ukraine could cement Moscow's gains. Mr Zelenskiy and other European leaders worry that would reward Mr Putin for nearly 11 years of efforts to seize Ukrainian land and embolden him to expand further west in Europe. [ European leaders eye Trump-Putin talks on Ukraine with anxiety Opens in new window ] A source familiar with the matter said Russian Special Envoy Kirill Dmitriev will participate in Friday's summit. Mr Dmitriev, who heads Russia's RDIF sovereign wealth fund, has previously held talks with Steve Witkoff, Mr Trump's special envoy, and has spoken of possible business co-operation between Moscow and Washington. Mr Trump's agreement last week to the summit was an abrupt shift after weeks of voicing frustration with Mr Putin for resisting the US peace initiative. A Gallup poll released last week found that 69 per cent of Ukrainians favour a negotiated end to the war as soon as possible. But polls also indicate Ukrainians do not want peace at any cost if that means significant concessions. As conditions for a ceasefire and the start of talks, Mr Putin has demanded that Ukraine withdraw its forces from four regions that Russia has claimed as its own but does not fully control, and formally renounce plans to join Nato. Kyiv swiftly rejected the conditions as tantamount to surrender. – Reuters
